Surgical Versus Percutaneous Drainage in the Management of High Grade Pancreatic Trauma
- Conditions
- Pancreatic TraumaTrauma
- Interventions
- Procedure: Percutaneous drainage strategyProcedure: Surgical drainage strategy
- Registration Number
- NCT04335474
- Lead Sponsor
- Nanjing PLA General Hospital
- Brief Summary
High-grade pancreatic injury is rare, and the reported complication and mortality are high.
The optimal management strategy according to high-grade injuries remains controversial.
The present study compares surgical drainage with percutaneous drainage in the management of High-grade pancreatic trauma.
- Detailed Description
High-grade pancreatic trauma (HGPT), while uncommon, presents challenging diagnostic and therapeutic dilemmas to trauma surgeons. Multiple management strategies to HGPT have been reported, which was associated with a high level of morbidity and mortality rate. Besides, few prospective studies have investigated the optimal management strategy of patients with HGPT.
We aimed to compare surgical drainage with percutaneous drainage in the management of HGPT. To do so, the strategy is to integrate precise prospective clinical records extensive clinical treatment data in a large cohort of patients. All the clinical departments, participating in the study, include patients, with tight collaboration between Trauma, Intensive Care and Surgery departments. Demographics and clinical parameters are collected in a database.
Once after the diagnosis is confirmed, the inclusion of patients is performed, before scheduled hospital management, and after eligibility criteria checking, and consent form signature. During clinical management, several samples are collected: blood samples and surgical specimens. As a usual practice, post-operative treatment will be prescribed at the investigator's discretion, with the help of an acre-established algorithm. Several samples are also collected during this exam(blood and biological tissue sample).
At the same time as these managements, clinical data regarding medical history, pre-hospital treatment history, surgical history, treatment history, post-operative treatment if prescribed, treatment history between surgery and image logical diagnosis are recorded. Clinical data are also collected 12months after discharge during a scheduled visit organized as usual practice, for long-term study.
Several studies will be performed along with the cohort setting-up:
* Comparison of the diagnosis time and treatment time of patients with HGPT
* Study of surgical methods and intraoperative conditions in patients with HGPT
* Study of ICU resuscitation treatment of patients with HGPT
* Study of complication, ICU length of stay and hospital length of stay for patients with HGPT
* Study of nutritional support treatment for patients with HGPT
* Study of mortality and cost for patients with HGPT
All the biologic samples are stored on sites at -80°C, or at room temperature depending on the samples: Samples collected in tubes, are sent immediately, at room temperature, to the central pathology department in Jinling Hospital, Nanjing, China. All the other samples, stored at -80°C, are sent to the research institute of General Surgery, Medical School of Nanjing University, China.
Samples analyses are performed by dedicated research centers: DNA, and RNA extraction for transcriptome analysis, histological analyzes, etc:
Histological analyzes: Analysis of the structure of the excised pancreas or intestinal tissue.
Molecular Biology: Whole-genome expression analyses are performed using microarray and followed by Gene Ontology and clustering analyses.
Microbiota: Bacterial composition of the ileal mucosa-associated microbiota is analyzed at the time of surgery using 16S (MiSeq, Illumina) sequencing. The obtained sequences are analyzed using the Qiime pipeline to assess composition, alpha and beta diversity.
Immunology: Phenotype of immune cells: Immune cells are extracted from blood and fresh mucosal tissues. The phenotype of these cells is analyzed by cytometry.
Analysis of neutrophil extracellular traps:
The concentrations of cell-free DNA, cell-free nucleosomes, neutrophil elastase(NE) and myeloperoxidase (MPO) were measured in sera and plasma byHuman Cell Death Detection ELISA or sandwich ELISA.
Pancreatic tissue was removed rapidly and divided into different parts for later analyses. One was used for confocal microscopy and one third was snap-frozen in liquid nitrogen for biochemical quantification of pancreatic myeloperoxidase(MPO), histone 3, and histone 4 levels, etc. One was fixed in formalin for histologic analysis.
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 80
- Patient diagnosed with high-grade pancreatic trauma by surgery
- Patient diagnosed with high-grade pancreatic trauma by computed tomography
- Patient diagnosed with high-grade pancreatic trauma by Endoscopic retrograde cholangiopancreatography (ERCP)
- Patient diagnosed with high-grade pancreatic trauma by Magnetic resonance cholangiopancreatography (MRCP)
- The patient underwent chemotherapies or radiotherapy
- Immune system disease
- Low-grade pancreatic trauma
- Accompanied by severe trauma to other organs
- End-stage chronic organ failure
- With multiple severe injuries
- Died within 24 h of admission
- Younger than 18 years
- Pregnant
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Percutaneous drainage Percutaneous drainage strategy Cases that have the nonoperative management by percutaneous drainage Surgical drainage Surgical drainage strategy Cases that have surgical management
- Primary Outcome Measures
Name Time Method 28-day mortality 28 days All cause mortality within 28 days
- Secondary Outcome Measures
Name Time Method Days to regular diet Through study completion, an average of 6 months The time from the treatment to the normal eating of patients with pancreatic trauma
Postoperative 28-day adverse effects 28 days All cause adverse effects within 28 days
Hospital length of stay Through study completion, an average of 6 months Length of hospital stay
Pancreatic associated complications Through study completion, an average of 1 year Complications due to pancreatic problems
Days on total parenteral nutrition Through study completion, an average of 6 months] Treatment time of parenteral nutrition support required during hospitalization
Time to enteral nutrition Through study completion, an average of 6 months Time from management to initiate enteral nutrition in pancreatic injury patients
Non-pancreatic associated complications Through study completion, an average of 1 year Abdominal complications of non-pancreatic problems
Systematic complication 28 days Complications such as pneumonia, abdominal sepsis, etc
Intensive Care Unit length of stay Through study completion, an average of 6 months Length of Intensive Care Unit stay
Organ failure 28 days Organ failure caused by organ dysfunction
Days to clear liquids Through study completion, an average of 6 months The time when the drainage tube is pulled out after the patient's abdominal liquids cleated
Trial Locations
- Locations (1)
Jinling Hospital
🇨🇳Nanjing, China